ERBB2 and breast cancer: BC is a heterogeneous disease, both in terms of epidemiology (sporadic tumors, tumors with BRCA mutations) and the expression of receptors: estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2).